| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | JQ-1:MK-0752 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | TPCA-1 | GDSC1000 | pan-cancer | AAC | 0.0013 | 1 |